Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Radiat Oncol. 2013 Jan 29;8:21. doi: 10.1186/1748-717X-8-21.
We performed this study to assess outcomes of patients with oropharyngeal cancer treated with modern therapy approaches.
Demographics, treatments and outcomes of patients diagnosed with Stage 3- 4B squamous carcinoma of the oropharynx, between 2000-2007 were tabulated and analyzed.
The cohort consisted of 1046 patients. The 5-year actuarial overall survival, recurrence-free survival and local-regional control rates for the entire cohort were 78%, 77% and 87% respectively. More advanced disease, increasing T-stage and smoking were associated with higher rates of local-regional recurrence and poorer survival.
Patients with locally advanced oropharyngeal cancer have a relatively high survival rate. Patients' demographics and primary tumor volume were very influential on these favorable outcomes. In particular, patients with small primary tumors did very well even when treatment was not intensified with the addition of chemotherapy.
我们进行本研究旨在评估采用现代治疗方法治疗口咽癌患者的结局。
对 2000-2007 年间诊断为 3-4B 期口咽鳞状细胞癌的患者的人口统计学特征、治疗方法和结局进行制表和分析。
该队列包括 1046 名患者。全组患者的 5 年实际总生存率、无复发生存率和局部区域控制率分别为 78%、77%和 87%。更晚期的疾病、T 分期的增加和吸烟与更高的局部区域复发率和较差的生存率相关。
局部晚期口咽癌患者的生存率相对较高。患者的人口统计学特征和原发肿瘤体积对这些有利的结局影响很大。特别是,即使不通过化疗来强化治疗,小原发肿瘤的患者也能取得很好的效果。